Thursday, September 13, 2018
AngioDynamics to acquire RadiaDyne
AngioDynamics to acquire RadiaDyne AngioDynamics announced an agreement to acquire, a privately held medical diagnostic and device company that designs and develops patient dose monitoring technology to improve cancer treatment outcomes. This transaction expands AngioDynamics’ growing Oncology business by adding RadiaDyne’s early-stage, proprietary OARtrac real-time radiation dose monitoring platform and other market-leading oncology solutions, including the IsoLoc/ImmobiLoc and Alatus balloon stabilizing technologies.
https://thefly.com/landingPageNews.php?id=2789799
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.